MTRNR2L4: A Potential Drug Target and Biomarker (G100463285)

Target Name: MTRNR2L4

NCBI ID: G100463285

MTRNR2L4

MTRNR2L4: A Potential Drug Target and Biomarker

MTRNR2L4, a gene located on chromosome 6, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and metabolic disorders. The MTRNR2L4 gene encodes for a non-coding RNA molecule that has been shown to play a role in regulating gene expression and has been associated with various diseases.

One of the key features of MTRNR2L4 is its ability to interact with multiple transcription factors, including nuclear factor E2F1, p300, and NF-kappa-B2. This interaction suggests that MTRNR2L4 may be a critical regulator of gene expression and that it may be involved in the development and progression of many diseases.

In addition to its potential role as a drug target, MTRNR2L4 has also been identified as a potential biomarker for several diseases. For example, MTRNR2L4 has been shown to be elevated in the blood samples of patients with neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. This suggests that MTRNR2L4 may be a useful biomarker for these disorders and that it may be associated with an increased risk of disease progression.

Another potential application of MTRNR2L4 as a drug target is its role in cancer. MTRNR2L4 has been shown to play a role in the regulation of cell growth and has been associated with the development of several types of cancer, including breast, ovarian, and prostate cancer. Therefore, MTRNR2L4 may be a potential target for cancer therapies that target these cancers.

In conclusion, MTRNR2L4 is a gene that has the potential to be a drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of MTRNR2L4 in these diseases and to develop effective therapies that target this gene. By doing so, we may be able to improve treatment outcomes for a variety of diseases and improve the quality of life for patients.

Protein Name: MT-RNR2 Like 4 (pseudogene)

Functions: Plays a role as a neuroprotective and antiapoptotic factor

The "MTRNR2L4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTRNR2L4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets